Researchers have announced progress on an RNA‑targeted treatment designed to correct specific genetic mutations. Early lab results show improved cellular response and reduced symptom severity in trial participants. Scientists believe this approach could pave the way for next‑generation therapies for rare hereditary diseases.
About the Author
